The EIC is inviting investors to hear from a select group of EIC-funded innovators working on ground-breaking MedTech solutions. This online event, held under the Ecosystem Partnerships and Co-Investment Support programme, will take place on July 7, between 13h30 and 15h00 CEST and feature highly promising MedTech companies. Register now to get to know the projects shaping the future of healthcare in Europe!
Bold, knowledgeable investors with a history in the healthcare sector and an interest in backing innovative MedTech solutions will now get their chance to hear from the best projects in the EIC portfolio.
Does this sound like you? Join us online, on July 7, between 13h30 and 15h00 CEST and discover the companies revolutionising healthcare as we know it.
Register for the event here!
Applications are open until 6 July 2022.
Who can apply?
The EIC is looking for qualified investors with a history of backing MedTech solutions. Venture Capitalists, Corporate VC Funds, Family Offices, Angel Investors and others are encouraged to apply.
Make sure you’ve signed up to the EIC Co-Investment Platform to make the most of the event.
Which companies will be featured?
You can find the preliminary list of featured projects below.
Please note that this is a preliminary list and might still be subject to additions and changes.
BOYDSense’s mission is to democratize health monitoring to improve people's life. BOYDSense is a French startup that develops a breath analysis platform relying on metabolomics and gas sensing technologies. By measuring volatile organic compounds (VOCs) in exhaled breath and leveraging the correlation with blood biomarkers, the miniaturized breath analyzer will provide useful and real-time information to monitor health. The first product/application in development named “Lassie” is dedicated to diabetes. The company is on a series A investment round, looking for 5M€.
Resistell is developing the world’s fastest Antibiotic Susceptibility Test (AST) which helps doctors in hospitals to find the right antibiotic treatment for the patient. The conventional methods of assessing microbial susceptibility to antibiotics take about 1-2 days to get the results. Their rapid AST will save patients’ lives and help preventing the spread of antibiotic resistance (AMR). They are on a series B funding round, looking for 5M€.
BrainCapture is a Danish startup developing an affordable, smartphone-connected EEG device that enables neurological-diagnostics-as-a-service aimed at the 4+ Billion people in emerging markets who lack consistent and affordable access to neurological care. This lack of access leads to millions of people going without diagnosis and treatment for conditions like Epilepsy. This disparity can be addressed with the tools of the 21st century - smartphones, connectivity, AI and automation - and represents an opportunity. They are creating an Electroencephalogram (EEG) device which is easy to use, and telemedicine optimized in order to offer EEG as a service throughout Africa, the Middle East, and Asia. Their value proposition is that medical facilities can adopt their solution at low or no up front cost, use existing nursing staff for data collection after a short training, and pay per-test, allowing them to expand their additional diagnostic offering and earn revenue without additional cost. The company is on a series A investment round, looking for 5M€.
Inovativy Medicina has developed Sentante – a smart, sensory, teleoperated robot system for endovascular interventions, which allows the procedure to be performed remotely, from a different room, or even different hospital. The system senses operators’ movements and provides close to natural haptic force feedback - physicians can feel the instrument resistance just as if they were standing near the patient. They are on a series A funding round, with a target investment ticket of 7M€.
Mode Sensors develops wearable sensor technology to support care providers and clinical decision-making. The Norwegian medical device company offers Re:Balans, a fluid management solution that quantifies changes in hydration in order to help patients stay hydrated, and prevent medical complications caused by fluid imbalances.
Akara Robotics is an Irish company developing new technologies for front-line healthcare workers. Akara offers an end-to-end disinfectant solution that can be deployed in hospitals, nursing homes and potentially endless other areas where harmful germs reside. The system uses a patent-protected, state-of-the-art disinfection robot known as ‘Violet’. They are also responsible for 'Stevie', a socially assistive robot developed to support frontline staff and residents in retirement community settings.
About the EIC Ecosystem Partnerships and Co-Investment Support Programme
The Ecosystem Partnerships and Co-Investment Support Programme is expanding the EIC’s Business Acceleration Services (BAS) by creating a network of specialized, sector-focused partners that can help innovators access the services they need. It is also dedicated to promoting co-investment along with the EIC Fund, by preparing beneficiaries to interact with investors and connecting them through matchmaking and dedicated events.
Should you have any questions regarding the event, please contact us through the email: joao.amaral@eicfund.eu.
About the EIC & the EIC Fund
The EIC is Europe’s flagship innovation programme, dedicated to identifying companies developing breakthrough innovations and supporting them in each stage of their lifecycle. Companies selected through its main funding instrument, EIC Accelerator, can receive grants (non-dilutive funding) up 2,5M EUR, to €15m in equity from the EIC Fund, a unique entity established to make direct investments in companies. In addition, the companies receive support to connect with investors, corporates, procurers and other relevant ecosystem players.
DISCLAIMER: This information is provided in the interest of knowledge sharing and should not be interpreted as the official view of the European Commission, or any other organisation.